In 2024, prostate cancer ... throughout the right lobe. Low-volume Gleason score 3 + 3 = 6 invasive adenocarcinoma and IDC-P were found contralaterally to the PI-RADS 5 lesion, in the left posterior ...

His initial presentation was with septic shock in the setting of a left lower lobe pneumonia. This was complicated by ... The diagnosis requires the measurement of basal and stimulated secretion of ...

Background: A 59-year-old man on exogenous androgen therapypresented with a clinically palpable prostate nodule confined ... predominantly within the anterior gland, which was not palpable on ...

Jan. 28, 2025 — The inherited mutated gene WNT9B, which functions normally in embryonic prostate development, increases risk of adult prostate cancer, according to a new ... Jan. 3, 2025 — In ...

Prostate cancer is now the most common cancer in the UK, according to new analysis - as a leading charity renewed its calls for a national screening program. NHS data found 55,033 men were ...

AZ cancers were more common in patients with known prostate cancer (Group 2–34.7%) than in patients with previous negative prostate biopsies (Group 1–21.8%) but this finding was not ...

Howard R. Soule, Ph.D., executive vice president and chief science officer of the Prostate Cancer Foundation, said, "These findings fill a therapeutic gap for patients with advanced prostate cancer.

Prostate cancer is the most common cancer for men in the UK, with one in eight diagnosed with the disease in their lifetime. The process uses existing ultrasound equipment which is widely ...

Over the past 14 years, clinicians have seen rapid growth in their therapeutic armamentarium to treat advanced prostate cancer. They can now choose among 4 novel second-generation hormone ...

The PubMed database was searched from January 2018 to May 2024. Articles were selected for inclusion if they reported on patients with metastatic prostate cancer who received a germline or somatic ...